Therapeutic hypothermia for neonatal encephalopathy

Current Treatment Options in Neurology

Volumn 14, Issue 6, 2012, Pages 608-619

  Shankaran, Seetha ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Adjuvant therapies; Knowledge gaps; Neonatal encephalopathy; Neonatal hypoxic ischemic encephalopathy . Pathophysiology . Neurodevelopmental outcome . Neuroprotection . Head cooling; Randomized controlled trials; Term infants; Therapeutic hypothermia; Treatment; Whole body cooling

Indexed keywords

ANTICONVULSIVE AGENT; GENTAMICIN; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; SEDATIVE AGENT;

ACIDOSIS; ADJUVANT THERAPY; ARTIFICIAL VENTILATION; BRAIN INJURY; BRAIN PROTECTION; CHILD GROWTH; CLINICAL EFFECTIVENESS; DEVELOPMENTAL, AGE AND GROWTH PARAMETERS; DISEASE COURSE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG METABOLISM; DRUG RESPONSE; ELECTROENCEPHALOGRAM; EVIDENCE BASED MEDICINE; EXCITOTOXICITY; HIGH TEMPERATURE; HOSPITAL DISCHARGE; HUMAN; HYPOCAPNIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; MATERNAL MORBIDITY; MATERNAL MORTALITY; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NEWBORN; NEWBORN DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT SAFETY; PATIENT TRANSPORT; PREMATURITY; PROGNOSIS; RESUSCITATION; REVIEW; SCALP COOLING; THERMOREGULATION; TREATMENT DURATION; TREATMENT OUTCOME; WHOLE BODY COOLING;

EID: 84870820418     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-012-0200-y     Document Type: Review

References (53)

1. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischemic encephalopathy. Early Hum Dev. 2010;86:329-38.
2. Shankaran S, Woldt E, Koepke T, et al. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev. 1991;25:135-48.
3. Robertson CMT. Long-term follow-up of term infants with perinatal asphyxia. In: Stevenson DK, Benitz WE, Sunshine P, editors. Fetal and neonatal brain injury. 3rd ed. New York: Cambridge University; 2003. p. 829-58.
4. De Vries LS, Jongmans MJ. Long-term outcome after neonatal hypoxic-ischemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2010;95:F220-4.
5. Marlow N, Rose AS, Rands CE, et al. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2005;90:F380-7.
6. Gonzalez FF, Miller SP. Does perinatal asphyxia impair cognitive function without cerebral palsy? Arch Dis Child Fetal Neonatal Ed. 2006;91:454-9.
7. Hope PL, Costello AM, Cady EB, et al. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet. 1984;2:366-70.
8. Azzopardi D, Wyatt JS, Cady EB, et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1989;25:445-51.
9. Lorek A, Takei Y, Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 1994;36:699-706.
10. Blumberg RM, Cady EB, Wigglesworth JS, et al. Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischemia in the developing brain. Exp Brain Res. 1997;113:130-7.
11. Johnston MV, Trescher WH, Ishida A, et al. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res. 2001;49:735-41.
12. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011;10:372-82.
13. Cross JL, Meloni BP, Bakker AJ, et al.Modes of neuronal calcium entry and homeostasis following cerebral ischemia. Stroke Res Treat. 2010;316862:1-9.
14. Hagberg H, Mallard C, Rousset CI, et al. Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol. 2009;24:1141-6.
15. Gunn AJ, Gunn TR, de Haan HH, et al. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 1997;99:248-56.
16. Gunn AJ, Bennet L, Gunning MI, et al. Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep. Pediatr Res. 1999;46(3):274-80.
17. Gluckman PD, Wyatt J, Azzopardi DV, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicenter randomized trial. Lancet. 2005;365:663-70.
18. Zhou WH, Cheng GQ, Shao XM, et al. Selective head cooling withmild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. J Pediatr. 2010;157:367-72, 372.e1-3.
19. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxicischemic encephalopathy. N Engl J Med. 2005;353:1574-84.
20. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009;361:1349-58. Largest trial of whole body cooling for neonatal HIE, very well controlled, and excellent follow rates.
21. Simbruner G, Mittal RA, Rohlmann F, et al. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics. 2010;126(4):e771-8.
22. Jacobs SE, Morley CJ, Inder TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165 (8):692-700. PMID: 21464374
23. Tagin MA, Woolcott CG, Vincer MJ, et al. Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2012;166(6):558-66.
24. Edwards AD, Brocklehurst P, Gunn AJ, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischemic encephalopathy: synthesis and meta-analysis of trial data. BMJ. 2010;9:340:c363. Excellent meta-analyses of trials for hypothermia for neuroprotection foe neonatal HIE.
25. Rutherford M, Ramenghi LA, Edwards AD, et al. Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischemic encephalopathy: a nested substudy of a randomized controlled trial. Lancet Neurol. 2010;9:39-45.
26. Shankaran S, Barnes, PD, Hintz SR, et al. Brain Injury Following Trial of hypothermia for neonatal hypox-ic-ischaemic encephalopathy. Arch Dis Child. 2012.1-9. doi:10.1136/archdischild-2011-301524.
27. Tam EWY, Haeusslein LA, Bonafacio SL, et al. Hypoglycemia is associated with increased risk of brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy. J Pediatr. 2012;161:88-93.
28. Ambalavanan N, Carlo WA, Shankaran S, et al. Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy. Pediatrics. 2006;118(5):2084-93.
29. Shankaran S, Pappas A, McDonald SA, et al. Predictive value of an early amplitude integrated electroencephalogram and neurologic examination. Pediatrics. 2011;128:e112-20.
30. Shankaran S, Laptook AR, Tyson JE, et al. Evolution of encephalopathy during whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2012;160:567-72.e3.
31. Shankaran S, Pappas A, Laptook AR, et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics. 2008;122:e791-8.
32. Wyatt JS, Gluckman PD, Liu PY, et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics. 2007;119(5):912-21.
33. Gunn AJ, Wyatt JS, Whitelaw A, et al. Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. J Pediatr. 2008;152:55-8; 58.e1. Epub 2007 Oct 24.
34. Kwon JM, Guillet R, Shankaran S, et al. Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the neonatal research network hypothermia trial. J Child Neurol. 2011;26(3):322-8.
35. Pappas A, Shankaran S, Laptook AR, et al. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2011;158:752-58.e1.
36. Laptook A, Tyson J, Shankaran S, et al. Elevated temperature after hypoxic-ischemic encephalopathy: A risk factor for adverse outcome. Pediatrics. 2008;122:491-9.
37. Shankaran S, Laptook AR, McDonald SA, et al. Temperature profile and outcomes of neonates undergoing whole body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatr Crit Care Med. 2012;13(1):53-9.
38. Sant'Anna G, Laptook AR, Shankaran S, et al. Phenobarbital and temperature profile during hypothermia for hypoxic-ischemic encephalopathy. J Child Neurol. 2012;27(4):451-7.
39. Kattwinkel J, Perlman JM, Aziz K, et al. Neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Pediatrics. 2010;126(5):e1400-13.
40. Perlman JM, Wyllie J, Kattwinkel J, et al. Neonatal Resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Pediatrics. 2010;126(5):e1319-44.
41. Zanelli S, Buck M, Fairchild K. Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J Perinatol. 2011;31(.6):377-86.
42. Róka A, Melinda KT, Vásárhelyi B, et al. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics. 2008;121(4):e844-9.
43. Liu X, Borooah M, Stone J, et al. Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics. 2009;124(1):310-5.
44. Filippi L, la Marca G, Cavallaro G, et al. Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia. Epilepsia. 2011;52(4):794-801.
45. van den Broek MP, Groenendaal F, Egberts AC, et al. Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharmacokinet. 2010;49(5):277-94.
46. Guillet R, EdwardsAD, ThoresenM, et al.Seven-to8-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy. Pediatr Res. 2012;71(2):205-9.
47. Shankaran S, Pappas A, McDonald SA, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366:2085-92.
48. Fairchild K, Sokora D, Scott J, et al. Therapeutic hypothermia on neonatal transport: 4-year experience in a single NICU. J Perinatol. 2010;30 (5):324-9.
49. Kendall GS, Kapetanakis A, RatnavelN, et al. Cooling on Retrieval Study Group. Passive cooling for initiation of therapeutic hypothermia in neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2010;95(6):F408-12.
50. Higgins RD, Raju T, Edwards AD, et al. Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr. 2011;159:851-8.
51. Robertson NJ, Tan S, Groenendaal F, et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr. 2012;160(4):544-52.e4.
52. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med. 2010;15(5):293-8.
53. Pimentel-Coelho PM, Rosado-de-Castro PH, da Fonseca LM, et al. Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy. Pediatr Res. 2012;71(4 Part 2):464-73.